Pulmonary-renal syndrome in systemic sclerosis: a report of three cases and review of the literature

References

• Medsger TA Jr. Systemic sclerosis (scleroderma): clinical aspects. In: Koopman, WJ, editor. Arthritis and allied conditions. 13th ed. Baltimore: Williams & Wilkins; 1997. p. 1433–64.
   Google Scholar
• Steen VD. Renal involvement in systemic sclerosis. Chin Dermatol 1994;12:253–8.
   Google Scholar
• Helfrich DJ, Banner B, Steen VD, Medsger TA Jr. Normotensive renal failure in systemic sclerosis. Arthritis Rheum 1989;32: 1128–34.
   Google Scholar
• Steen VD, Medsger TA Jr. Case-control study of corticosteroids and other drugs that either precipitate or protect from the develop-ment of scleroderma renal crisis. Arthritis Rheum 1998;41:1613–9.
   PubMed Web of Science ®Google Scholar
• Steen VD, Costantino JP, Shapiro AP, Medsger TA Jr. Outcome of renal crisis in systemic sclerosis: relation to availability of angio-tensin converting enzyme (ACE) inhibitors. Ann Intern Med 1990;113:352–7.
   Google Scholar
• Naniwa T, Banno S, Takahashi N, Maeda S, Hayami Y, Ueda R. Normotensive scleroderma renal crisis with diffuse alveolar damage after corticosteroid therapy. Mod Ftheumatol 2005;15:134–8.
   PubMedGoogle Scholar
• Subcommittee for scleroderma criteria of the American Rheuma-tism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581–90.
   PubMed Web of Science ®Google Scholar
• Nanke Y, Akama H, Yamanaka H, Hara M, Kamatani N. Progres-sive appearance of overlap syndrome together with autoantibodies in a patient with fatal thrombotic microangiopathy. Am J Med Sci 2000;320:348–51.
   Google Scholar
• Endo H, Hosono T, Kondo H. Antineutrophil cytoplasmic auto-antibodies in 6 patients with renal failure and systemic sclerosis. J Ftheumatol 1994;21: 864–70.
   Google Scholar
• Kumagai Y, Yamagata J, Hamamoto T, Okada T, Okada M, Fu-kuda Y, et al. Autopsy case of progressive systemic sclerosis (PSS) associated with rapidly progressive glomerulonephritis (RPGN) and diffuse intra-alveolar pulmonary hemorrhage-differentiation from Goodpasture's syndrome. Ryumachi 1983;23:212–20.
   Google Scholar
• Bar J, Ehrenfeld M, Rozenman J, Perelman M, Sidi Y, Gur H. Pulmonary-renal syndrome in systemic sclerosis. Semin Arthritis Rheum 2001;30:403–10.
   PubMed Web of Science ®Google Scholar
• Devogelaer JP, Pirson Y, Vandenbroucke JM, Cosyns JP, Brichard S, Nagant de Deuxchaisnes C. D-penicillamine induced crescentic glomerulonephritis: report and review of the literature. J Ftheuma-tol. 1987;14:1036–41.
   Google Scholar
• Derk CT, Jimenez SA. Goodpasture-like syndrome induced by D-penicillamine in a patient with systemic sclerosis: report and review of the literature. J Ftheumatol 2003;30:1616–20.
   Google Scholar
• Hara I, Miyake H. A case of progressive systemic sclerosis com-plicated by crescentic glomerulonephritis and diffuse pulmonary hemorrhage. Nippon Jinzo Gakkai Shi 1992;34:827–33.
   Google Scholar
• Phillips D, Phillips B, Mannino D. A case study and national da-tabase report of progressive systemic sclerosis and associated con-ditions. J Womens Health 1998;7:1099–104.
   Google Scholar
• Rajaraman S, Pinto JA, Cavallo T. Glomerulonephritis with co-existent immune deposits and antibasement membrane activity. J Clin Pathol 1984;37:176–81.
   Google Scholar
• Jara LJ, Vera-Lastra 0, Conejo MC. Pulmonary-renal vasculitic disorders: differential diagnosis and management. Curr Ftheumatol Rep 2003;5: 107–15.
   Google Scholar
• Wutzl AL, Foley RN, O'Driscoll BR, Reeve RS, Chisholm R, Herrick AL. Microscopic polyangiitis presenting as pulmonary-renal syndrome in a patient with long-standing diffuse cutaneous systemic sclerosis and antibodies to myeloperoxidase. Arthritis Rheum 2001;45:533–6.
   Google Scholar
• Steen VD. Renal involvement in systemic sclerosis. In: Clements PJ, Furst DE, editors. Systemic sclerosis. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 279–92.
   Google Scholar
• Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, et al. Comparison of plasma exchange with plasma infu-sion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 1991;325:393–7.
   PubMed Web of Science ®Google Scholar
• Manadan AM, Harris C, Block JA. Thrombotic thrombocytopenic purpura in the setting of systemic sclerosis. Semin Arthritis Rheum 2005;34:683–8.
   Google Scholar
• FurIan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998;339:1578–84.
   Google Scholar
• Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998;339:1585–94.
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Yagi H, Ishizashi H, Wada H, Fujimura Y. The Japanese experience with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Semin Hematol 2004;41:68–74.
   Google Scholar
• Zheng XL, Kaufman RM, Goodnough LT, Sadler JE. Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura. Blood 2004; 103:4043–9.
   PubMed Web of Science ®Google Scholar
• Kallenbach J, Prinsloo I, Zwi S. Progressive systemic sclerosis com-plicated by diffuse pulmonary haemorrhage. Thorax 1977;32:767–70.
   Google Scholar
• Vazquez-Del Mercado M, Mendoza-Topete A, Best-Aguilera CR, Garcia-De La Torre I. Diffuse alveolar hemorrhage in limited cu-taneous systemic sclerosis with positive perinuclear antineutrophil cytoplasmic antibodies. J Ftheumatol 1996;23:1821–3.
   Google Scholar
• Chaer RA, Massad MG, Evans A, Olopade C, Varga J. Systemic sclerosis complicated by diffuse alveolar hemorrhage. Med Sci Monit 2001;7:1013–5.
   Google Scholar
• Highland KB, Silver RM. Clinical aspects of lung involvement: lessons from idiopathic pulmonary fibrosis and the scleroderma lung study. Curr Ftheumatol Rep 2005;7:135–41.
   PubMedGoogle Scholar